Recent developments in the Synthetic Cannabinoids Market underscore accelerating innovation in the United States—from next-generation compounds to advanced delivery systems and commercialization strategies. For a detailed overview, see the Synthetic Cannabinoids Market Developments.U.S. pharmaceutical firms are increasingly filing INDs (Investigational New Drug applications) for synthetic...
Synthetic cannabinoids in oncology — the established and investigational applications of synthetic cannabinoid compounds in cancer supportive care (chemotherapy-induced nausea and vomiting, cancer-related anorexia, cancer pain), and the emerging preclinical evidence for direct anti-tumor properties — create the oncology market dimension of pharmaceutical synthetic cannabinoids, with...